GNMX
State Street’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-17,213
| Closed | -$3K | – | 3830 |
|
2019
Q4 | $3K | Hold |
17,213
| – | – | ﹤0.01% | 3806 |
|
2019
Q3 | $3K | Hold |
17,213
| – | – | ﹤0.01% | 3805 |
|
2019
Q2 | $3K | Hold |
17,213
| – | – | ﹤0.01% | 3813 |
|
2019
Q1 | $3K | Hold |
17,213
| – | – | ﹤0.01% | 3742 |
|
2018
Q4 | $12K | Hold |
17,213
| – | – | ﹤0.01% | 3729 |
|
2018
Q3 | $21K | Sell |
17,213
-3,287
| -16% | -$4.01K | ﹤0.01% | 3735 |
|
2018
Q2 | $23K | Hold |
20,500
| – | – | ﹤0.01% | 3723 |
|
2018
Q1 | $42K | Hold |
20,500
| – | – | ﹤0.01% | 3672 |
|
2017
Q4 | $25K | Hold |
20,500
| – | – | ﹤0.01% | 3681 |
|
2017
Q3 | $26K | Hold |
20,500
| – | – | ﹤0.01% | 3708 |
|
2017
Q2 | $27K | Sell |
20,500
-341,975
| -94% | -$450K | ﹤0.01% | 3640 |
|
2017
Q1 | $674K | Buy |
362,475
+16,777
| +5% | +$31.2K | ﹤0.01% | 3342 |
|
2016
Q4 | $1.79M | Buy |
345,698
+46,149
| +15% | +$239K | ﹤0.01% | 3139 |
|
2016
Q3 | $1.67M | Buy |
299,549
+6,397
| +2% | +$35.6K | ﹤0.01% | 3041 |
|
2016
Q2 | $1.63M | Buy |
293,152
+36,152
| +14% | +$201K | ﹤0.01% | 3106 |
|
2016
Q1 | $1.13M | Buy |
257,000
+35,496
| +16% | +$156K | ﹤0.01% | 3189 |
|
2015
Q4 | $1.34M | Buy |
221,504
+58,465
| +36% | +$353K | ﹤0.01% | 3134 |
|
2015
Q3 | $1.28M | Buy |
163,039
+50,966
| +45% | +$399K | ﹤0.01% | 3155 |
|
2015
Q2 | $688K | Buy |
112,073
+92,073
| +460% | +$565K | ﹤0.01% | 3314 |
|
2015
Q1 | $160K | Buy |
+20,000
| New | +$160K | ﹤0.01% | 3509 |
|